SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
medcases00
Published on Aug 22, 2021
A Division of Hospital Medicine Grand Rounds presented by Steven Coca, DO, MS, Associate Chair for Clinical and Translational Research, Associate Professor of Medicine (Nephrology)
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
01:02:49"Cardio-renal Risk Reduction Across the Spectrum of Type 2 DM" presented by Anip Bansal
44 views 915 days ago -
Watch Later
34:00Iris De Castro, MD - SGLT2 inhibitor in Kidney Transplantation: Is it ready for prime time?
50 views 1171 days ago -
Watch Later
45:18Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
50 views 917 days ago -
Watch Later
!["Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH]()
51:21"Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH
46 views 875 days ago -
Watch Later
!["Updates in Adult Minimal Change Disease" presented by Ruth Campbell]()
51:21"Updates in Adult Minimal Change Disease" presented by Ruth Campbell
52 views 897 days ago -
Watch Later
!["Atypical Uses of Peritoneal Dialysis" presented by Ruth Campbell]()
37:35"Atypical Uses of Peritoneal Dialysis" presented by Ruth Campbell
52 views 897 days ago
